Case Study: US-Based Pharmaceutical Company enhances disease taxonomy and clinical trial outcomes with Quantzig's real-world evidence analytics

Pharmaceutical Drug Development Firm Enhanced Disease Taxonomy & Clinical Trial Outcomes with Real World Evidence Analytics

Quantzig worked with a US-Based Pharmaceutical Company that wanted to improve the success rate of clinical trials and streamline drug development. The customer was struggling with unstructured and unorganized information, lengthy clinical trials, and the need to improve disease taxonomy by using real-world data analytics and AI-driven insights.

Quantzig combined predictive analytics with real-world data analytics to unify disparate data sources, identify issues in patient selection, and support better disease classification. As a result, Quantzig helped the customer organize unstructured information, reduce clinical trial duration, improve outcomes, enhance disease taxonomy, gain better insight into real-world treatment effectiveness, and add automated regulatory alerts, though no specific numerical impact was provided.